Study #PA12-1006
Establishing a Tumor Registry for Patients with Neuroendocrine Carcinoma of the Cervix
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This study collects information and data on patients with neuroendocrine cervical cancer. Information from this study may be used to better understand the correlation between clinical data, such as patient characteristics, treatment, and disease outcomes, and overall patient outcomes.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Cervical Large Cell Neuroendocrine Carcinoma;Cervical Neuroendocrine Carcinoma;Cervical Small Cell Carcinoma;Cervical Undifferentiated Carcinoma;Stage I Cervical Cancer AJCC v8;Stage IA Cervical Cancer AJCC v8;Stage IA1 Cervical Cancer AJCC v8;Stage IA2 Cervical Cancer AJCC v8;Stage IB Cervical Cancer AJCC v8;Stage IB1 Cervical Cancer AJCC v8;Stage IB2 Cervical Cancer AJCC v8;Stage II Cervical Cancer AJCC v8;Stage IIA Cervical Cancer AJCC v8;Stage IIA1 Cervical Cancer AJCC v8;Stage IIA2 Cervical Cancer AJCC v8;Stage IIB Cervical Cancer AJCC v8;Stage III Cervical Cancer AJCC v8;Stage IIIA Cervical Cancer AJCC v8;Stage IIIB Cervical Cancer AJCC v8;Stage IV Cervical Cancer AJCC v8;Stage IVA Cervical Cancer AJCC v8;Stage IVB Cervical Cancer AJCC v8
Study phase:
Physician name:
Larissa Meyer
Department:
Gynecologic Oncology & Reproductive Medicine
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.